Welcome to our dedicated page for Lifevantage news (Ticker: LFVN), a resource for investors and traders seeking the latest updates and insights on Lifevantage stock.
LifeVantage Corporation (Nasdaq: LFVN) is a health and wellness company centered on nutrigenomics and cellular activation, and its news flow reflects this focus. The company regularly issues updates on its activator-based product portfolio, consultant community, scientific research, and participation in investor and industry events. As the Activation company, LifeVantage highlights how its products, such as the Protandim family, TrueScience Liquid Collagen, the MindBody GLP-1 System, and the comprehensive gut activator P84, fit into broader wellness systems and scientific narratives.
News about LifeVantage often covers new product launches and enhancements, including additions to its activation-supporting nutrients, AXIO nootropic energy drink mixes, and TrueScience skin and hair care line. Company communications also describe major field events like Momentum Academy and Global Kickoff, where Consultants receive training, hear about new tools, and learn strategies related to enrollment, retention, and advancement. These events frequently coincide with the introduction of new offerings or the integration of acquired product lines such as LoveBiome’s P84.
Investors following LFVN can also expect announcements on quarterly and annual financial results, dividend declarations, share repurchase activity, and guidance ranges, as well as notices of participation in conferences and fireside chats. The company’s releases include commentary from management on strategic initiatives such as integrating LoveBiome assets, expanding its wellness ecosystem, and advancing digital capabilities like the Daily Activation app.
This news page aggregates these updates so readers can track developments in LifeVantage’s product science, consultant network, and corporate strategy in one place. For anyone monitoring LFVN stock, the consultant-driven business model, or trends in nutrigenomics-focused wellness products, the news feed provides an ongoing view of how the company communicates its progress and priorities.
LifeVantage Corporation (Nasdaq: LFVN) reported record fiscal 2020 revenue of $233 million, marking a 3.1% increase year-over-year. The fourth quarter alone generated $59.4 million in revenue, a 5.7% increase from the previous year. Adjusted EBITDA rose 31.3% to $24 million. The company ended the fiscal year with strong cash flow, holding $22.1 million in cash and zero debt. Earnings per share for fiscal 2020 were $0.79, up from $0.50 in fiscal 2019. Looking ahead, the company expects $240 million to $251 million in revenue for fiscal 2021.
LifeVantage Corporation (Nasdaq: LFVN) reported third-quarter fiscal 2020 revenue of $56.1 million, a slight increase from the previous year. Adjusted EBITDA rose 26.4% to $5.1 million. Revenue in the Americas declined 0.5%, while Asia/Pacific & Europe saw a 1.6% increase. Total active accounts decreased 3.8% sequentially. Q3 earnings per diluted share were $0.11, compared to $0.12 last year. The company reiterated adjusted EPS guidance of $0.74 to $0.79 for fiscal 2020, anticipating revenue will fall below earlier estimates due to the pandemic.